Contributors of Campbell-Walsh-Wein, 12th edition
Richard Nithiphaisal Yu, David Andrew Diamond, and Richard C. Rink
Normal sexual development
Normal sexual development can be categorized into three processes: establishment of genotypic (chromosomal) sex, establishment of phenotypic sex, and formation of gender identity. Disruption of any of these interactions is described as a disorder of sexual development (DSD).
During the first 6 weeks of development, the gonadal ridge, germ cells, internal ducts and external genitalia are bipotential in both 46,XY and 46,XX embryos . Multiple genes are thought to determine chromosomal sex. Specifically, the SRY (sex-determining region Y) gene on the Y chromosome is considered the testis-determining factor . Under this influence, the bipotential gonadal ridges differentiate into testes, and germ cells develop into spermatocytes ( Fig. 10.1 ). In the absence of SRY, ovarian organogenesis results ( Table 10.1 ).
MALE | EMBRYONIC STRUCTURE | FEMALE |
---|---|---|
|
|
|
|
|
|
|
|
|
Gubernaculum testis | Gubernaculum |
|
| Mesonephric tubules |
|
|
|
|
| Intermediate mesoderm |
|
Appendix of testis | Müllerian duct (paramesonephric duct) |
|
| Urogenital sinus |
|
| Genital tubercle |
|
Ventral aspect of penis | Urethral folds/vestibular folds | Labia minora |
Scrotum | Labioscrotal swellings | Labia majora |
The Sertoli cells of the testis secrete anti-Müllerian hormone (AMH) at 7 to 8 weeks of gestation, which promotes Müllerian duct regression. Testosterone secretion by the fetal testis Leydig cells occurs at approximately 9 weeks of gestation. Androgens promote virilization of wolffian duct structures, the urogenital sinus, and the genital tubercle. Testosterone enters target tissues by passive diffusion, and wolffian duct virilization does not occur if local androgens are not present. In some cells, testosterone is converted to dihydrotestosterone (DHT) by intracellular 5α-reductase. Testosterone or DHT then binds to an intracellular androgen receptor. DHT binds to the receptor with greater affinity and stability than does testosterone. In tissues equipped with 5α-reductase at the time of sexual differentiation (e.g., prostate, urogenital sinus, external genitalia), DHT is the active androgen. Masculinization of the external genitalia is complete by 12–13 weeks of gestation ( Fig. 10.2 ). Penile growth and testicular descent occur over the third trimester. In the female fetus, the absence of testosterone maintains the appearance of external genitalia at the 6-week gestational stage ( Fig. 10.3 ).
The wolffian ducts adjacent to the testes form the epididymis, joining with the rete testes. Distally the wolffian ducts join the urogenital sinus to develop into the seminal vesicles. In the female fetus without testosterone, the wolffian ducts regress. Without AMH, the Müllerian ducts develop into the female internal reproductive tract, including the fallopian tubes and uterus. Contact of the ducts with the urogenital sinus ultimately forms the vagina. It is generally accepted that the proximal two thirds of the vagina is formed from the Müllerian ducts and the distal third from the urogenital sinus ( Fig. 10.4 ).
Formation of gender identity is a complex and poorly understood phenomenon. Research suggests that gender identity may be affected not only by chromosomal sex and prenatal hormones but also postnatal environmental factors.
Terminology and definitions
The most widely used terminology for the myriad conditions of abnormal sexual differentiation is disorders of sexual development (DSD) , or disorders of sexual differentiation. Although there is no clear consensus, individuals affected by DSD may prefer the term difference of sex development, intersex, or more specific terminology to the diagnosis, such as androgen insensitivity syndrome ( Table 10.2 ).
CLASSIFICATION | INCIDENCE | EXAMPLES | PATHOPHYSIOLOGY | PRESENCE OF GONADS |
---|---|---|---|---|
1. Disorders of Gonadal Differentiation and Development | ||||
Klinefelter Syndrome | 1/600 (classic) | Classic 47,XXY: meiotic nondisjunction | Bilateral testes | |
46,XX Male | 1/20,000 | Translocation of Y chromosome material to X chromosome | Bilateral testes | |
Gonadal Dysgenesis | ||||
Turner syndrome | 1/2500 | Classic 45,X; presence of one normal X chromosome and absent/abnormal other chromosome/mosaicisim | Bilateral streak (dysgenetic) gonads (primary follicles described in some) | |
46,XX “pure” gonadal dysgenesis | Bilateral streak (dysgenetic) gonads | |||
Mixed gonadal dysgenesis | Second most common cause of ambiguous genitalia in neonates | Most 45,XO/46,XY | Unilateral testis, contralateral streak gonad | |
Partial gonadal dysgenesis | 45,X/46,XY or 46,XY | Bilateral dysgenetic testes | ||
46,XY “pure” gonadal dysgenesis (Swyer syndrome) | Complete absence of testis-determining factor; mutations in SRY gene in some | Bilateral dysgenetic testes | ||
Embryonic Testicular Regression/Bilateral Vanishing Testes Syndrome | 46,XY; loss of testicular tissue during embryogenesis | Bilateral hemosiderin deposition | ||
2. Ovotesticular DSD | ||||
(True hermaphroditism) | 46,XX, 46,XY or mosaicism | Two ovotestes or one ovary/one testis | ||
3. 46,XX DSD | ||||
(Female pseudohermaphroditism) | ||||
Congenital Adrenal Hyperplasia | 1/5000–15,000 (21-hydroxylase) | 21-Hydroxylase, 11β-hydroxylase deficiencies | Inborn error of metabolism in one of enzymes involved in cortisol production; increased testosterone production | Bilateral ovaries |
Maternal Androgen Excesst | Exogenous androgen effects on fetal development | Bilateral ovaries | ||
4. 46,XY DSD (Male pseudohermaphroditism) | ||||
Leydig Cell Agenesis/Unresponsiveness | Leydig cell aplasia or abnormal LH receptor | Bilateral testes | ||
Disorders of Testosterone Biosynthesis (CAH variants) | StAR deficiency, 3β-hydroxysteroid dehydrogenase deficiency | Defect of enzymes converting cholesterol to testosterone | Bilateral testes | |
Disorders of Androgen-Dependent Target Tissue | ||||
Syndrome of complete androgen insensitivity | 1/20,000–1/60,000 | X-linked; androgen resistance secondary to abnormality of androgen receptor | Bilateral testes | |
Syndrome of partial androgen insensitivity | X-linked; androgen resistance secondary to abnormality of androgen receptor | Bilateral testes | ||
Mild androgen insensitivity syndrome | Androgen resistance secondary to abnormality of androgen receptor | Bilateral testes | ||
5α-Reductase deficiency | Abnormality in type II isoenzyme that converts testosterone to DHT | Bilateral testes | ||
Persistent Müllerian duct syndrome | Abnormality of AMH gene or receptor | Bilateral testes | ||
5. Unclassified DSD | ||||
Mayer-Rokitansky-Küster-Hauser Syndrome | 1/4000–5000 | 46,XX, genetic basis unknown | Bilateral ovaries |